✦ LIBER ✦

A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study

✍ Scribed by Dimitrios Bafaloukos; Helena Linardou; Gerasimos Aravantinos; Christos Papadimitriou; Aristotelis Bamias; George Fountzilas; Haralabos P Kalofonos; Paris Kosmidis; Eleni Timotheadou; Thomas Makatsoris; Epaminondas Samantas; Evangelos Briasoulis; Christos Christodoulou; Pavlos Papakostas; Dimitrios Pectasides; Athanasios M Dimopoulos

Book ID: 115022064
Publisher: BioMed Central
Year: 2010
Tongue: English
Weight: 332 KB
Volume: 8
Category: Article
ISSN: 1741-7015
DOI: 10.1186/1741-7015-8-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-line chemotherapy with gemcitabin

Second-line chemotherapy with gemcitabine and carboplatin in paclitaxel-pretreated, platinum-sensitive ovarian cancer patients: A Hellenic Cooperative Oncology Group Study

✍ Christos A Papadimitriou; George Fountzilas; Gerassimos Aravantinos; Charalambos 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 142 KB

A phase II study of paclitaxel in platin

A phase II study of paclitaxel in platinum pretreated ovarian cancer. A hellenic cooperative oncology group study

✍ G. Aravantinos; D.V. Skarlos; P. Kosmidis; A. Athanassiades; D. Bafaloukos; T. G 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 427 KB

Carboplatin and Paclitaxel versus Cispla

Carboplatin and Paclitaxel versus Cisplatin, Paclitaxel and Doxorubicin for first-line chemotherapy of Advanced Ovarian Cancer: A Hellenic Cooperative Oncology Group (HeCOG) study

✍ Gerasimos Aravantinos; George Fountzilas; Aristotelis Bamias; Irene Grimani; Spy 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Paclitaxel, carboplatin and pegylated li

Paclitaxel, carboplatin and pegylated liposomal doxorubicin in ovarian and peritoneal carcinoma: A phase I study of the Gynecologic Oncology Group

✍ Peter G. Rose; Benjamin E. Greer; Ira R. Horowitz; Maurie Markman; Nancy Fusco 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Single agent carboplatin versus carbopla

Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: Final survival results of a SWOG (S0200) phase 3 randomized trial

✍ Maurie Markman; James Moon; Sharon Wilczynski; Ana Maria Lopez; Kendrith M. Rowl 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 218 KB

Carboplatin and pegylated liposomal doxo

Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial

✍ Gladieff, L.; Ferrero, A.; De Rauglaudre, G.; Brown, C.; Vasey, P.; Reinthaller, 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 124 KB